Navigation Links
Optimer Reports Fourth Quarter and Fiscal Year 2012 Financial Results
Date:2/28/2013

JERSEY CITY, N.J., Feb. 28, 2013 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today unaudited financial results for the fourth quarter and fiscal year ended December 31, 2012.  

(Logo: http://photos.prnewswire.com/prnh/20090413/LA97352LOGO )

Financial Highlights

  • 2012 DIFICID net product sales in the U.S. and Canada of $62.4 million, compared to $21.5 million in 2011
  • A 14.3% increase in U.S. and Canadian DIFICID shipments in the fourth quarter, resulting in net sales of $16.8 million
  • 2012 contract revenue from collaborations, which include up-front payments, milestones, royalties and product sales, were $39.1 million
  • 2012 total revenues were $101.5 million
  • Cash, cash equivalents and short-term investments at December 31, 2012 totaled $124.0 million
  • 2012 net loss was $37.0 million, or $0.78 per share, and 2012 net income for the fourth quarter was $1.0 million, $0.02 per share
  • "2012 was an exciting year for Optimer.  DIFICID is now available in over a dozen countries," said Dr. Henry McKinnell, Optimer's CEO and Chairman of the Board.  "In the U.S. we will be focusing on improving the formulary status of DIFICID in the hospital marketplace and on expanding the use of this important new medicine in all channels."

    Financial Overview 
    Total revenue for the years ended December 31, 2012 and 2011 was $101.5 million and $145.0 million, respectively.  Total revenue for the fourth quarter 2012 and 2011 was $19.5 million and $64.6 million, respectively.  The decreases were due to a reduction in contract revenue, which in 2011 included $122.7 million from the Astellas Pharma Europe (APEL) agreement, offset by increases in
    '/>"/>

    SOURCE Optimer Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Optimer Pharmaceuticals Board of Directors Appoints Board Chairman, Dr. Henry McKinnell, Chief Executive Officer
    2. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Fiscal Year 2012 Financial Results
    3. Optimer Pharmaceuticals to Present at Leerink Swann Global Healthcare Conference
    4. Optimer Pharmaceuticals to Present at 23rd Annual Oppenheimer Healthcare Conference
    5. Optimer Pharmaceuticals to Present at November 2012 Investor Conferences
    6. Optimer Pharmaceuticals Reports Third Quarter 2012 Financial Results
    7. Optimer Pharmaceuticals to Present at September 2012 Investor Conferences
    8. Optimer Pharmaceuticals to Present at the Canaccord Genuity 32nd Annual Growth Conference
    9. Optimer Pharmaceuticals Appoints Stephen Newman to Its Board of Directors
    10. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2012 Financial Results
    11. Optimer Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/22/2014)... JUNCTION, N.J. , Dec. 22, 2014 /PRNewswire/ ... company marketing its CytoSorb® blood purification technology to ... surgery patients in 28 countries worldwide, today announced ... Russo , MD, FACS, as its Senior Vice ... Dr. Di Russo ...
    (Date:12/22/2014)... DUBLIN , Dec. 22, 2014 Research and ... addition of the "US Self-monitoring Blood Glucose Market" ... http://photos.prnewswire.com/prnh/20130307/600769 This market insight focuses ... in the United States . Reimbursement ... studied. Thorough product analyses for more than 73 SMBG ...
    (Date:12/22/2014)... a privately-held medical products and technologies company, today announced ... Officer of the company, effective December 22, 2014. ... Board of Directors of ConvaTec thanks Mr. Berger for ... years," said Magnus Lundberg , the Chairman of ... company is well positioned for the future."  The company ...
    Breaking Medicine Technology:CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 5US Self-monitoring Blood Glucose Market 2ConvaTec Names Paul Moraviec Interim CEO Effective December 22, 2014 2
    ... Scientific Corporation (NYSE: BSX ) today announced ... of Los Gatos, California.  The transaction follows the definitive ... terms of the agreement, Boston Scientific paid $193 million ... equity not already owned by Boston Scientific.  Additional payments ...
    ... 4, 2011 ERT (Nasdaq: ERES ), announced ... and Keith Schneck, the Company,s Chief Financial Officer, are scheduled ... at 9:30 AM PST on January 13, 2011 in San ... by visiting the Company,s corporate website at http://www.ert.com . ...
    Cached Medicine Technology:Boston Scientific Completes Acquisition of Sadra Medical 2Boston Scientific Completes Acquisition of Sadra Medical 3Boston Scientific Completes Acquisition of Sadra Medical 4ERT to Present at the 29th Annual J.P. Morgan Healthcare Conference on January 13, 2011 2
    (Date:12/26/2014)... Cooking and warming equipment ... 5. This score reflects slightly positive negotiation conditions for ... low switching costs and a low level of price ... availability of substitutes for cooking and warming equipment and ... aluminum, key inputs in the production process of this ...
    (Date:12/26/2014)... (PRWEB) December 26, 2014 Plugin and template ... TransPack Volume 5 Plugin for Final Cut Pro X. , ... hard light tool to pull off an industry professional look” ... get their hands on TransPack Volume 5, a new level ... is a set of over 50 Final Cut Pro X ...
    (Date:12/26/2014)... Pentec Health, Inc. number fourteen on the Best ... 2014. The awards program, created in 2000, is one ... the country. The program is a public/private partnership between ... Economic Development, the Pennsylvania State Council of the Society ... Journal. , Charlie Wilson, Vice President of ...
    (Date:12/25/2014)... 2014 The microscopy market is ... to reach $5,756.0 million by 2019. Optical microscopy ... The electron microscopes product segment is expected to ... , Rising focus on nanotechnology, technological advancements, and ... microscopy market. , Get Full Copy of Report ...
    (Date:12/25/2014)... December 26, 2014 The report ... to 2023” focuses on the current treatment landscape, ... the colorectal cancer market. Stivarga is a drug ... or rectal cancer. Boehringer Ingelheim is developing nintedanib ... treatment of refractory CRC in the US, Europe, ...
    Breaking Medicine News(10 mins):Health News:Cooking & Warming Equipment Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Cooking & Warming Equipment Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Today a new plugin was announced from Pixel Film Studios, TransPack Volume 5 for Final Cut Pro X 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4
    ... have discovered a new gene mutation they say causes ... Swiss family with Parkinson,s disease, using advanced DNA sequencing technology. ... of Human Genetics , was led by neuroscientists at the ... U.S., Canada, Europe, United Kingdom, Asia and the Middle East. ...
    ... July 15 (HealthDay News) -- After undergoing the weight-loss ... routine can help patients continue to lose weight and ... didn,t know until now whether morbidly obese bariatric surgery ... Dr. Abhimanyu Garg, chief of nutrition and metabolic diseases ...
    ... , FRIDAY, July 15 (HealthDay News) -- Injection drug ... regardless of what types of drugs they use, according ... users suffer higher rates of abuse, dependence and other ... help treatment programs specialize their care to target these ...
    ... for Medical Systems Biology (BIMSB) of the Max Delbrck ... be the first academic research institution in Continental Europe ... of single DNA molecules in real time. The SMRT ... high-throughput technologies. The researchers of the BIMSB will use ...
    ... HealthDay Reporter , THURSDAY, July 14 (HealthDay News) -- ... include smoking has dropped for the fifth year in a row, ... 72 percent drop since 2005 in smoking images in movies rated ... to 595 in 2010. In addition, the average number of smoking ...
    ... By Alan Mozes HealthDay Reporter , THURSDAY, July ... virus responsible for many well-known illnesses in humans and animals ... in another, according to researchers. This "jumping" virus is ... pneumonia and many other illnesses in humans. Until now -- ...
    Cached Medicine News:Health News:Mayo researchers: Genetic mutation linked to Parkinson's disease 2Health News:Rigorous Exercise May Boost Benefits of Weight-Loss Surgery 2Health News:Injection Drug Users Most in Need of Treatment, Study Says 2Health News:Novel DNA sequencer for MDC's systems biology 2Health News:Less Lighting Up in Movies Aimed at Kids 2Health News:Less Lighting Up in Movies Aimed at Kids 3Health News:Novel Virus 'Jumped' From Monkeys to Humans, Researchers Find 2Health News:Novel Virus 'Jumped' From Monkeys to Humans, Researchers Find 3Health News:Novel Virus 'Jumped' From Monkeys to Humans, Researchers Find 4
    ... Continuous centralized monitoring with wireless connectivity, ... feature for the S/5 monitoring system that ... Monitor and S/5 FM to the S/5 ... ,Wireless operation is a flexible way of ...
    ... for anesthesia., ,The S/5 Anesthesia Monitor (AM) ... and upgradeable solution for routine to the most ... parameter modules, you can choose the set of ... And when your needs evolve, the modularity of ...
    ... in the operating and recovery room, ... for combined haemodynamic and airway gas monitoring ... anesthesia care units. The Cardiocap II is ... the basic haemodynamic measurements. Two of the ...
    Anesthetists Precordial Kit incudes one set of 4 chromed plated chest pieces, a reusable monoscope of your choice, and 20 precordial adhesive discs....
    Medicine Products: